Matthew H. Birenbaum, Executive Vice President and Chief Development Officer of Vivmark Residential, filed a Form 4 on November 17, 2026, disclosing transactions in common shares of beneficial interest dated November 13, 2026.

Key Highlights

  • Sale of 7,500 shares: Birenbaum disposed of 7,500 Common Shares of Beneficial Interest on November 13, 2026, at an average price of $64.28 per share.
  • Price range: According to the filing, the shares were sold within a range of $64.27 to $64.29.
  • Gift of 770 shares: Also on November 13, 2026, 770 shares were disposed of under transaction code G at a price of $0.
  • Post-transaction ownership: Following both transactions, Birenbaum directly held 264,479 Common Shares of Beneficial Interest, including restricted shares scheduled to vest in the future.
  • Reporting person role: Birenbaum is identified in the filing as Executive Vice President and Chief Development Officer of VMRK:NASDAQ -- the filing lists the issuer as Vivmark Residential with ticker VMRK.

Birenbaum's November 13 Transactions in Vivmark Residential Shares

According to the Form 4 filed on November 17, 2026, Matthew H. Birenbaum, identified as Executive Vice President and CDO of Vivmark Residential (VMRK), reported two transactions in Common Shares of Beneficial Interest on November 13, 2026. The first was a disposition of 770 shares under transaction code G at a price of $0, reducing his direct holdings from an implied prior amount. The second was a sale of 7,500 shares at an average price of $64.28 per share.

The filing notes that the $64.28 figure represents the average sale price, with individual transactions occurring within a range of $64.27 to $64.29. The filing states that Birenbaum "will provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price." Following both reported transactions, Birenbaum's direct beneficial ownership stood at 264,479 Common Shares of Beneficial Interest.

The filing clarifies, per footnote 1, that the direct total "includes restricted shares of Vivmark Residential scheduled to vest in the future." No derivative securities transactions were reported in Table II. The Form 4 was signed by Samantha Thompson as attorney-in-fact on November 17, 2026, and was filed as an individual, single-reporting-person form with no indication of a Rule 10b5-1 plan checkbox being selected.

What Was Disclosed

Birenbaum's Form 4 disclosed a gift of 770 shares and a sale of 7,500 Common Shares of Beneficial Interest in Vivmark Residential on November 13, 2026, leaving him with 264,479 shares held directly, inclusive of unvested restricted shares.